Sumitomo Pharma Co., Ltd.
OTC: SMDPY0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Toru Kimura
- Employees
- 4,980
- Headquarters
- Osaka, Japan
- IPO year
- 2022
- Market cap
- $4.1B
- Website
- https://www.sumitomo-pharma.com
Loading SMDPY…
Loading profile data…Frequently asked questions about SMDPY
What does Sumitomo Pharma Co., Ltd. (SMDPY) do?
Sumitomo Pharma Co., Ltd. operates as a global entity focused on the development, manufacturing, and distribution of a diverse range of products. Its primary offerings include pharmaceutical drugs, food components and additives, and veterinary treatments. The company's reach extends across Japan, North America, China, and various other internati...
Where does SMDPY trade?
Sumitomo Pharma Co., Ltd. (SMDPY) trades on the Other OTC.
What sector is SMDPY in?
Sumitomo Pharma Co., Ltd. (SMDPY) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Sumitomo Pharma Co., Ltd.?
Toru Kimura is the chief executive officer of Sumitomo Pharma Co., Ltd. (SMDPY).
Where is Sumitomo Pharma Co., Ltd. headquartered?
Sumitomo Pharma Co., Ltd. is headquartered in Japan.
Does SMDPY pay a dividend?
Sumitomo Pharma Co., Ltd. (SMDPY) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did SMDPY go public?
Sumitomo Pharma Co., Ltd. (SMDPY) completed its initial public offering in 2022.
Is SMDPY an ADR?
Yes — SMDPY is an American Depositary Receipt; its underlying shares trade on a non-US exchange. Sumitomo Pharma Co., Ltd. reporting and dividends follow the underlying issuer.